---

Cerebral Palsy - Comprehensive Neurology Notes

---

1. DEFINITION

1. A disorder of movement and posture (weakness, spasticity, dystonia, ataxia, or choreoathetosis) with onset prior to age 1-2 years
2. Reliable evidence that the disorder is due to a disturbance in the fetal or infant brain
3. No evidence of progression or worsening over time
4. Significant functional limitation in the performance of desired activities
5. Reasonable expectation that the disorder will persist throughout life

Despite the nonprogressive nature of the underlying lesion (historically called "static encephalopathy"), the clinical expression changes dynamically with growth, maturation, and aging. CP is therefore better understood as a dynamic, evolving disorder rather than a fixed static condition. - Bradley and Daroff's Neurology in Clinical Practice

---

2. EPIDEMIOLOGY

• Most common neuromotor disorder of childhood
• Overall incidence: approximately 2 per 1000 live births
• Prevalence inversely proportional to gestational age:
  • Term births: 1-2 per 1000
  • Very premature infants: 40-60 per 1000
• Life expectancy is strongly linked to severity:
  • Ambulatory, self-feeding 15-year-olds: projected additional 55 years
  • Immobile, tube-fed 15-year-olds: projected additional 13 years
• Dyskinetic CP carries the highest mortality among subtypes
• Factors increasing mortality: female sex, cognitive impairment, epilepsy
• Common causes of death: aspiration pneumonia, urinary tract infections, sepsis, seizures, fractures

---

3. ETIOLOGY AND RISK FACTORS

Prenatal Causes

• Congenital brain malformations
• Intrauterine infections (TORCH: Toxoplasma, Rubella, CMV, Herpes)
• Genetic/chromosomal abnormalities
• Maternal trauma, toxin exposure
• Placental insufficiency

Perinatal Causes

• Periventricular leukomalacia (PVL) - most common cause in preterm infants; white matter injury from ischemia or infection
• Hypoxic-ischemic encephalopathy (HIE) - most common cause in term infants
• Intraventricular hemorrhage (IVH)
• Neonatal stroke
• Kernicterus (bilirubin toxicity to basal ganglia - classic cause of dyskinetic CP)
• Neonatal sepsis/meningitis

Postnatal Causes (first 2 years)

• Meningitis/encephalitis
• Traumatic brain injury (including non-accidental injury)
• Stroke
• Anoxia/near-drowning

---

4. NEUROPATHOLOGY AND NEUROANATOMY

Pathophysiology of Spasticity (Upper Motor Neuron Syndrome)

• Increased tendon reflexes with radiation
• Clonus
• Positive Babinski sign
• Involuntary activation of remote muscles
• Spasticity
• Extensor and flexor spasms

• Muscle weakness
• Loss of dexterity
• Fatigability
• Loss of selective control of muscle and limb segments
• Nonmotor changes: cognition, communication, behavioral, sleep disturbance

"Positive features are more amenable to active intervention but of less relevance to overall disability. Negative features, characterized by a reduction in motor activity, are more causative to disability." - Bradley and Daroff's Neurology in Clinical Practice

---

5. CLASSIFICATION

A. By Type of Motor Involvement

I. Spastic CP (80% of all cases)

• Upper motor neuron lesion; pyramidal tracts involved
• Velocity-dependent increased tone (clasp-knife), clonus, hyperreflexia, Babinski sign
• Further classified by topographic distribution:

II. Dyskinetic CP (15% of extrapyramidal cases)

• Extrapyramidal lesion (basal ganglia/thalamus)
• Lead-pipe or candle-wax rigidity; variable tone; clonus may be absent or present
• Subtypes:
  • Dystonic: Involuntary sustained/repetitive twisting movements and postures; often painful; reflects basal ganglia pathology
  • Choreoathetoid: Irregular, writhing, purposeless movements (chorea + athetosis combined); classic in kernicterus
  • Athetoid: Slow, writhing distal movements

III. Ataxic CP (~5%)

• Cerebellar origin
• Hypotonia, intention tremor, wide-based gait, dysmetria, dysdiadochokinesia
• Impaired balance and coordination

IV. Hypotonic CP

• Axial, appendicular, or generalized hypotonia
• Often reflects diffuse, severe cerebral and/or cerebellar cortical dysfunction
• Many evolve into spastic or dyskinetic subtypes with age

V. Mixed CP

• Combination of features, most commonly spastic + dyskinetic

B. Functional Classification - GMFCS

• GMFCS has been shown to be predictive of hip dislocation risk
• GMFCS IV/V: ~50% risk of developing scoliosis
• Remains stable and reliable as a prognostic tool after age 2

C. Manual Abilities Classification System (MACS)

• Five-level system assessing how a child uses hands in activities of daily living
• Ages 4-18 years; validated with good-to-excellent interrater reliability
• Mirrors GMFCS concept but applied to upper limb function

---

6. CLINICAL FEATURES AND ASSOCIATED CONDITIONS

Motor Features

• Abnormal tone (spastic, dystonic, hypotonic, or mixed)
• Abnormal movement patterns and primitive reflexes persisting beyond expected age
• Contractures and musculoskeletal deformities (hip dislocation, equinus foot, scoliosis)
• Gait abnormalities

Common Gait Patterns in Spastic CP

• Equinus gait (toe-walking): plantarflexion deformity, gastrocnemius spasticity
• Crouch gait: hip and knee flexion, excessive ankle dorsiflexion
• Scissor gait: hip adductor spasticity causing legs to cross midline
• Stiff-knee gait: failure of knee flexion in swing due to rectus femoris spasticity
• Trendelenburg gait: hip abductor weakness

Associated Conditions (Comorbidities)

---

7. DIAGNOSIS

Clinical Criteria

Key History Points

• Perinatal history: prematurity, birth complications, APGAR scores, need for resuscitation
• Developmental milestones: delayed or abnormal motor milestones
• Family history to exclude hereditary spastic paraplegias
• History of infection, trauma, or anoxia in the first 2 years

Clinical Examination Findings

• Primitive reflex persistence beyond expected age: Moro, ATNR (asymmetric tonic neck reflex), palmar grasp
• Absent protective/equilibrium reactions past expected age
• Hyperreflexia, clonus, Babinski sign (in spastic types)
• Abnormal tone patterns
• Hand preference before 18 months strongly suggests hemiplegia

Investigations

• MRI brain: abnormal in 70-90% of individuals with CP; identifies white matter injury, cortical malformations, basal ganglia lesions
• EEG: if seizures suspected
• Metabolic screen: rule out inborn errors of metabolism (especially if atypical features)
• Genetic testing: chromosome microarray, whole exome sequencing if etiology unexplained
• Hearing evaluation, visual assessment, ophthalmology review
• Swallowing assessment (videofluoroscopic swallow study)

Once a diagnosis of CP is suspected, classification follows based on the predominant movement abnormality: spastic, dyskinetic, or hypotonic-ataxic, and then further by topographic distribution. - Bradley and Daroff's Neurology in Clinical Practice

---

8. PHYSIOTHERAPY ASSESSMENT

8A. Assessment Principles

• Body structure/function (tone, strength, ROM, reflexes)
• Activity (functional motor abilities)
• Participation (school, community, home roles)
• Contextual factors (environment, assistive devices)

---

8B. Subjective Assessment

• Chief complaint and primary functional goals
• Birth history, neonatal course, diagnosis timeline
• Current medications (especially antispasmodics)
• Feeding method (oral vs. gastrostomy)
• Seizure history and control
• Pain: location, triggers, character, impact on function
• Mobility aids currently in use
• School placement and participation level
• Sleep patterns

---

8C. Objective Assessment Tools

1. Tone Assessment

• Modified Ashworth Scale (MAS): Grades spasticity 0-4 based on resistance during passive movement
• Modified Tardieu Scale (MTS): Preferred over MAS; distinguishes spasticity (velocity-dependent) from contracture (velocity-independent); measures R1 (reflex catch angle) and R2 (full passive ROM)
  • Spasticity angle = R2 - R1; larger angle = more spasticity
• Hypertonia Assessment Tool (HAT): Differentiates spasticity, dystonia, and rigidity

2. Gross Motor Function

• Gross Motor Function Measure (GMFM-88 and GMFM-66): Gold standard for measuring gross motor ability; 5 dimensions: Lying/Rolling, Sitting, Crawling/Kneeling, Standing, Walking/Running/Jumping
• GMFCS (as above): functional classification/prognosis

3. Selective Motor Control

• Selective Control Assessment of the Lower Extremity (SCALE): Tests selective voluntary movement at hip, knee, ankle, subtalar, toes
• Each joint graded: Normal (2), Impaired (1), Unable (0)

4. Muscle Strength

• Manual Muscle Testing (MMT) - modified for pediatric use
• Hand-held dynamometry for quantitative measurement

5. Range of Motion

• Goniometry for all key joints
• Key measurements in CP:
  • Hip: flexion, extension (Thomas test for hip flexion contracture), abduction, internal/external rotation
  • Knee: flexion contracture, popliteal angle (hamstring tightness)
  • Ankle: dorsiflexion with knee extended (gastrocnemius) and knee flexed (soleus)
  • Silverskiold test: differentiates gastrocnemius from soleus tightness

6. Gait Analysis

• Observational Gait Scale (OGS): Standardized visual gait analysis tool
• Edinburgh Visual Gait Scale (EVGS): Systematic video-based gait analysis
• 3D Instrumented Gait Analysis (IGA): Gold standard; provides kinematics, kinetics, and EMG data to guide surgical and therapeutic decisions
• Timed Up and Go (TUG): Functional mobility and fall risk
• 10-Meter Walk Test (10MWT): Walking speed

7. Balance Assessment

• Pediatric Balance Scale (PBS): Adapted from Berg Balance Scale for children
• Functional Reach Test
• Balance Error Scoring System (BESS)

8. Activity and Function Scales

• Pediatric Evaluation of Disability Inventory (PEDI): Self-care, mobility, social function
• Functional Mobility Scale (FMS): Rates walking ability over 5m, 50m, 500m distances
• Goal Attainment Scaling (GAS): Individualized goal setting and outcome measurement

9. Quality of Life

• Cerebral Palsy Quality of Life Questionnaire (CP QOL-Child)
• KIDSCREEN

10. Pain Assessment

• Wong-Baker FACES Pain Scale (for children)
• Non-Communicating Children's Pain Checklist (NCCPC): for non-verbal children
• Comfort scale for children who cannot self-report

11. Hip Surveillance

• Reimer's Migration Percentage (MP) on X-ray: the proportion of femoral head uncovered by the acetabulum
  • MP > 40%: indicated for intervention
  • Frequency of surveillance guided by GMFCS level (higher GMFCS = more frequent X-rays)

---

9. PHYSIOTHERAPY MANAGEMENT

9A. Overarching Goals

1. Maximize functional independence and mobility
2. Prevent/minimize secondary complications (contractures, deformity, pain)
3. Optimize participation in home, school, and community
4. Support caregiver education and home program adherence
5. Coordinate with the multidisciplinary team (physiatry, orthopaedics, neurology, OT, SLT)

---

9B. Stretching and Range of Motion

• Passive stretching: Daily stretching of spastic muscles (gastrocnemius, hamstrings, hip adductors, hip flexors, wrist/finger flexors)
• Prolonged low-load stretch (>30 minutes) more effective than brief stretching for preventing contracture
• Evidence suggests passive stretching alone has limited long-term benefit for tone reduction but does maintain ROM and reduce contracture risk

---

9C. Strengthening

• Progressive resistance training: Safely effective in CP; targets weak antagonist muscles
• Addresses the negative features of UMN syndrome (weakness, loss of dexterity)
• Focus muscles: hip extensors and abductors, knee extensors, ankle dorsiflexors
• Does NOT worsen spasticity (evidence-based reassurance)

---

9D. Neurodevelopmental Treatment (NDT / Bobath Approach)

• Aims to inhibit abnormal movement patterns and facilitate normal movement patterns
• Hands-on facilitation through key points of control
• Focus on achieving normal postural reactions and selective movement
• Widely used but evidence base is moderate; best as part of broader intensive therapy

---

9E. Task-Specific and Functional Training

• Intensive task-specific training: High repetition of functional tasks (standing, stepping, reaching) drives neuroplasticity
• Constraint-Induced Movement Therapy (CIMT): For hemiplegic CP; constrains the unaffected hand to force use of the affected hand; strong evidence for upper limb function improvement
• Treadmill training / Partial body-weight supported treadmill training (PBWSTT): Improves gait speed and endurance, especially in ambulatory CP

---

9F. Postural Management

• 24-hour postural management: Addressing posture across all positions (lying, sitting, standing) throughout the day and night
• Positioning equipment: Specialist seating systems, standing frames, sleep systems
• Spinal management: Seating modifications and TLSO bracing for scoliosis management (especially GMFCS IV-V)

---

9G. Orthotics

• Ankle-Foot Orthoses (AFOs): Most commonly prescribed
  • Solid AFO: controls equinus in low activity, prevents plantarflexion
  • Hinged/articulated AFO: allows dorsiflexion, used in crouch gait
  • Ground Reaction AFO (GRAFO): resists crouch gait with anterior shell
  • Supramalleolar Orthosis (SMO): addresses subtalar instability
• Knee-Ankle-Foot Orthoses (KAFO): For knee instability
• Hip abduction orthoses: To maintain hip range and reduce dislocation risk
• Thumb and wrist splints: For upper limb management in hemiplegia

---

9H. Hydrotherapy

• Warm water reduces muscle tone
• Buoyancy facilitates movement and reduces fear
• Cardiovascular fitness, balance, and gait training
• Particularly beneficial for GMFCS III-V who struggle with land-based therapy

---

9I. Electrical Stimulation

• Neuromuscular Electrical Stimulation (NMES): Stimulates weakened muscles (e.g., ankle dorsiflexors, quadriceps) to improve strength and function
• Transcutaneous Electrical Nerve Stimulation (TENS): Pain management
• Functional Electrical Stimulation (FES): Applied during gait for drop foot correction

---

9J. Hippotherapy and Equine-Assisted Therapy

• Rhythmic movement of horse approximates pelvic motion in human gait
• Improves trunk control, balance, postural tone, and motor function
• Good evidence for GMFCS I-III

---

10. PHARMACOLOGICAL MANAGEMENT OF SPASTICITY

---

11. SURGICAL MANAGEMENT

Soft Tissue Procedures

• Heel cord lengthening (TAL): For equinus deformity
• Hamstring lengthening: For crouch gait with knee flexion contracture
• Hip adductor release: Prevents/treats hip dislocation
• Rectus femoris transfer: For stiff-knee gait
• Split anterior tibial tendon transfer (SPLATT): For varus foot deformity

Bony Procedures

• Femoral varus derotation osteotomy (VDRO): For hip subluxation/dislocation
• Periacetabular/Dega osteotomy: Improves acetabular coverage
• Subtalar fusion / Calcaneal lengthening: For planovalgus foot

Neurological Procedures

• Selective Dorsal Rhizotomy (SDR): Surgical sectioning of sensory rootlets (L1-S2) to reduce spasticity; best evidence for ambulatory diplegia (GMFCS II-III); irreversible; requires intensive post-op physiotherapy
• Deep Brain Stimulation (DBS): For dystonic CP; growing evidence base; targets globus pallidus internus (GPi)

Spinal Surgery

• Posterior spinal fusion for scoliosis (GMFCS IV-V with curves >50 degrees)
• Complications reported in up to 81% of CP cases (including 15-19% infection rate)

---

12. PROGNOSIS AND LONG-TERM OUTCOMES

• CP is a lifelong condition but with modern management, most individuals survive into adulthood
• Ambulatory potential largely determined by GMFCS level and presence of sitting balance by age 2
• Rule of 2s for ambulation prediction:
  • If independent sitting by age 2 → likely independent ambulation
  • If not sitting by age 4 → ambulation unlikely
• Adults with CP face accelerated aging, increased musculoskeletal pain, fatigue, and risk of secondary conditions
• Regular surveillance and transition to adult services is essential

---

13. MULTIDISCIPLINARY TEAM

---

• Bradley and Daroff's Neurology in Clinical Practice - Chapter 111 (Cerebral Palsy)
• Campbell's Operative Orthopaedics 15th Ed 2026 - Chapter 35 (Cerebral Palsy)
• Miller's Review of Orthopaedics 9th Edition
• The Harriet Lane Handbook 23rd Edition - Chapter 9 (Table 9.9)
• Creasy & Resnik's Maternal-Fetal Medicine

---

Cerebral Palsy - Investigations in Detail

---

OVERVIEW

1. Identify the underlying etiology of the brain injury or malformation
2. Exclude progressive neurological conditions that may mimic CP (CP mimics)
3. Identify treatable causes (certain metabolic/genetic disorders)
4. Screen for and monitor comorbidities (epilepsy, visual, hearing, cognitive, nutritional, orthopedic)

"Although CP is a clinical diagnosis, all children should undergo investigations to identify the underlying cause and exclude progressive conditions." - Royal Children's Hospital Clinical Practice Guidelines

---

I. NEUROIMAGING

A. Magnetic Resonance Imaging (MRI) Brain

• Abnormal in 70-90% of individuals with CP
• Provides information on type, severity, and timing of brain injury
• In approximately 15-18% of cases, MRI is normal or nonspecific - this should raise suspicion for an underlying genetic or metabolic etiology

• MRI with T1, T2, FLAIR, DWI, and susceptibility-weighted sequences
• DTI (Diffusion Tensor Imaging) and tractography for white matter tract visualization (specialist centers)
• Performed under sedation/general anesthesia in young or uncooperative children
• Optimal timing: 2-8 years of age (myelination complete, lesions most visible)
• In the neonatal period, early MRI (day 3-5 of life) and term-equivalent age MRI (36-40 weeks corrected) are most informative in preterm infants

"Imaging generally correlates with the findings on clinical examination - involvement of the pyramidal tract in spastic CP and of the basal ganglia or cerebellum in dyskinetic or ataxic subtypes. It is estimated that up to 70% of patients with dyskinetic CP have imaging evidence of involvement of the thalamus and basal ganglia." - Bradley and Daroff's Neurology in Clinical Practice

• Refers to injury to deep cerebral white matter in two patterns:
  • Focal periventricular necrosis: Coagulative necrosis → cyst formation or focal glial scars, most common at trigone of lateral ventricles and foramen of Monro
  • Diffuse white matter injury: Affects premyelinating oligodendrocytes → global loss of oligodendrocytes → white matter volume loss and ventriculomegaly
• Pathogenesis: hypoxia-ischemia → free radical exposure + cytokine toxicity + excitatory neurotransmitter (glutamate) excess
• Classic sequela: spastic diplegia (descending motor fibers for lower limbs traverse periventricular area)
• MRI more sensitive than cranial ultrasound for diffuse PVL

---

B. Cranial Ultrasound (Head Ultrasound - HUS)

• Used in the neonatal and early infant period (before anterior fontanelle closes, ~18 months)
• Portable, no sedation required, safe, repeatable
• Indications: All preterm infants <32 weeks; term infants with HIE, suspected IVH, or clinical risk factors
• Findings:
  • Intraventricular hemorrhage (IVH) - Papile grading I-IV:
    • Grade I: Subependymal (germinal matrix) hemorrhage
    • Grade II: IVH without ventricular dilatation
    • Grade III: IVH with ventricular dilatation
    • Grade IV: Intraparenchymal hemorrhage (periventricular hemorrhagic infarction)
  • Periventricular echogenicity - suggesting PVL (though less sensitive than MRI for diffuse injury)
  • Periventricular cysts - cystic PVL (highly predictive of CP)
  • Hydrocephalus - post-hemorrhagic
• Limitation: Fails to identify subtle diffuse white matter injury; MRI is superior for confirmation
• Serial HUS recommended: at birth (for IVH), 7-14 days, 36-40 weeks corrected age

---

C. CT Scan (Computed Tomography)

• Less preferred than MRI due to radiation exposure and lower soft tissue contrast
• Use in emergencies: Acute postnatal injury, suspected non-accidental trauma, urgent assessment where MRI is unavailable
• May identify:
  • Calcifications (congenital infections: TORCH)
  • Subdural hemorrhage
  • Gross structural abnormalities
• Not recommended as routine first-line investigation in stable children

---

D. Advanced MRI Techniques (Specialist Indications)

---

II. ELECTROENCEPHALOGRAM (EEG)

• Routine EEG (awake and sleep): First-line; minimum 30-60 minutes including sleep
• Prolonged/Ambulatory EEG (24-72 hours): When seizures are frequent but not captured on routine EEG
• Video-EEG Telemetry: Gold standard for seizure characterization and pre-surgical epilepsy evaluation; correlates clinical behavior with EEG changes
• Neonatal EEG / aEEG (amplitude-integrated EEG): Continuous monitoring in NICU for birth asphyxia; identifies subclinical seizures; predicts neurodevelopmental outcome

• Focal epileptiform discharges (sharp waves, spikes): Hemiplegic CP, focal cortical injury
• Multifocal epileptiform activity: Quadriplegic, extensive cortical damage
• Hypsarrhythmia: Infantile spasms (West syndrome) - associated with severe structural CP
• Diffuse slowing: Severe cortical dysfunction
• Background abnormalities (burst suppression): Severe HIE in neonatal period; poor prognostic indicator

---

III. METABOLIC INVESTIGATIONS

• MRI is normal or nonspecific
• Clinical course appears progressive (challenging a pure CP diagnosis)
• Symptoms worsen with fasting, febrile illness, or intercurrent stress
• Atypical features are present (family history, consanguinity, regression of milestones)
• Initial genetic testing is negative but suspicion persists

Routine Metabolic Screen

CSF Analysis (Cerebrospinal Fluid)

"Inborn errors of metabolism can sometimes go undetected under the guise of a CP diagnosis, some potentially treatable. The absence of visible structural CNS injury (especially if the history lacks risk factors) should raise concern for an underlying genetic condition." - Bradley and Daroff's Neurology in Clinical Practice

Key Metabolic CP Mimics to Identify (as they are treatable)

---

IV. GENETIC INVESTIGATIONS

• 10% of CP cases have pathogenic chromosomal copy number variants (Oskoui et al., 2015)
• 14% of CP cases have identifiable single gene disorders on whole exome sequencing (McMichael et al., 2015)

• Normal or atypical MRI
• No plausible acquired perinatal/postnatal etiology
• Progressive features or regression of milestones
• Dysmorphic features, microcephaly, or multiple congenital anomalies
• Family history of similar condition; consanguinity
• Bilateral cortical malformations (lissencephaly, polymicrogyria, heterotopia)
• Ataxic CP without clear structural cerebellar lesion
• Clinical actionability expected (e.g., precision therapy available)

Genetic Tests Available

• L-serine or memantine in GRIN1/GRIN2A (NMDA receptor variants)
• 4-aminopyridine or acetazolamide in CACNA1A
• Caffeine in ADCY5
• JAK inhibitors in interferonopathies
• Deep brain stimulation for dyskinetic crises: GNAO1, UBA5, KMT2B

---

V. NEONATAL INVESTIGATIONS (Perinatal Period)

---

VI. HEARING ASSESSMENT

• Hearing loss present in approximately 10% of children with CP
• Increased risk of both conductive (recurrent otitis media) and sensorineural hearing loss
• Sensorineural hearing loss particularly associated with kernicterus (bilirubin damage to cochlear nuclei and auditory pathways) and neonatal meningitis

---

VII. VISION AND OPHTHALMOLOGICAL ASSESSMENT

• Vision problems in 30-50% of children with CP
• Strabismus (squint): Most common; occurs in ~40%
• Cortical Visual Impairment (CVI): Due to injury to visual cortex or optic radiations; most common cause of visual impairment in children with CP
• Refractive errors (myopia, hypermetropia, astigmatism): Common
• Homonymous hemianopia: In hemiplegia (damage to optic radiations)
• Nystagmus: Associated with cerebellar CP
• Optic atrophy: In severe global brain injury

---

VIII. COGNITIVE AND DEVELOPMENTAL ASSESSMENT

• Intellectual disability in up to 45% of children with CP (range highly variable by subtype)
• Formal assessment before school entry to guide educational placement and support

---

IX. SPEECH AND LANGUAGE ASSESSMENT

• Communication disability is common, from dysarthria to complete anarthria
• Feeding/swallowing problems are major causes of morbidity

---

X. MUSCULOSKELETAL AND ORTHOPEDIC INVESTIGATIONS

Hip Surveillance X-ray

• Most important routine orthopedic investigation in CP
• Mandatory surveillance program because hip dislocation is a major preventable complication
• Reimer's Migration Percentage (MP): Proportion of femoral head lateral to Perkin's line; normal <25%

• MP 25-40%: Close surveillance + physiotherapy
• MP >40%: Surgical referral indicated
• Spastic quadriplegia (GMFCS IV-V) has ~60-70% risk of hip displacement if untreated

Spinal X-ray

• Screening for scoliosis; lateral/AP views
• Particularly important in GMFCS III-V
• Cobb angle measurement to quantify curvature
• Serial X-rays to monitor progression
• GMFCS IV-V patients have ~50% risk of scoliosis

Gait Analysis (3D Instrumented Gait Analysis - IGA)

• Kinematics (joint angles), kinetics (forces and moments), EMG (muscle activity), energy expenditure
• Gold standard for surgical decision-making in ambulatory CP
• Performed at specialist gait labs; age >4-5 years for reliable data

Bone Density (DEXA Scan)

• Osteopenia/osteoporosis common in non-ambulatory CP (GMFCS IV-V)
• Indicated in: non-ambulatory children, limited sun exposure, nutritional deficiency, long-term AED use
• DXA scan of lumbar spine and total body

---

XI. NUTRITIONAL AND GROWTH MONITORING

---

XII. UROLOGICAL INVESTIGATIONS

• Neurogenic bladder common in CP (up to 50% of quadriplegic CP)
• May present as urinary incontinence, retention, recurrent UTI, or upper tract damage

---

XIII. RESPIRATORY INVESTIGATIONS

• Restrictive lung disease, aspiration pneumonia, and sleep-disordered breathing are common

---

XIV. SUMMARY TABLE: Investigation Pathway in CP

---

• Bradley and Daroff's Neurology in Clinical Practice - Chapter 111
• Creasy & Resnik's Maternal-Fetal Medicine - Periventricular Leukomalacia
• The Harriet Lane Handbook 23rd Edition - Chapter 9
• Royal Children's Hospital Clinical Practice Guidelines: Cerebral Palsy (RCH Melbourne)
• Metabolic and Genetic Disorders Mimicking Cerebral Palsy - PMC8015517
• Oskoui et al. (2015); McMichael et al. (2015) - Genetic causes of CP

---

Cerebral Palsy - Medical Management in Detail

---

OVERVIEW AND PRINCIPLES

• CP requires a multidisciplinary team (MDT) approach at all stages
• Medical interventions should be embedded within a rehabilitation context and guided by individual patient goals
• Treatment categories - pharmacological, rehabilitative, and surgical - are not sequential but integrated simultaneously
• The ICF framework guides management: treat impairments, but with eyes on activity and participation

"The treatment strategy for cerebral palsy is best developed in a multidisciplinary setting where medical interventions are embedded in a rehabilitation context considering the patient's individual goals. Integration of therapies provides the most benefit rather than a sequential approach." - Bradley and Daroff's Neurology in Clinical Practice

---

I. MANAGEMENT OF SPASTICITY

---

A. Oral / Enteral Pharmacological Agents

1. Baclofen (First-line)

2. Tizanidine

3. Dantrolene Sodium

4. Diazepam (Benzodiazepine)

5. Clonidine

6. Gabapentin

---

B. Focal / Chemo-denervation Agents

7. Botulinum Toxin Type A (BoNT-A) - Most Important Focal Agent

"Targeted injections combined with rehabilitative therapies can allow for improved motor functioning and delay/avoidance of orthopedic surgery. Repeat injections are performed every 4-6 months to avoid development of resistance." - Bradley and Daroff's Neurology in Clinical Practice

8. Phenol and Ethyl Alcohol Nerve Blocks

---

C. Intrathecal Baclofen (ITB) Pump

• Only a small fraction of oral baclofen crosses the blood-brain barrier
• ITB delivers baclofen directly into the CSF at the spinal cord level
• Acts directly on GABA-B receptors in dorsal horn → more potent effect at a fraction of the systemic dose
• Reduces systemic side effects while achieving superior spasticity control
• Reversible - can be discontinued; unlike SDR

• Programmable pump surgically implanted in the anterior abdominal wall (subcutaneous)
• Connected to an intrathecal catheter threaded to the appropriate spinal level
• Delivers continuous infusion; programmable for bolus doses at specific times (e.g., increased at night)
• Pump reservoir refilled every 2-6 months via transcutaneous needle injection into the silicone port
• Pump battery life: 5-7 years → surgical replacement required
• Prior to implantation: test dose (50-100 mcg intrathecal bolus) to confirm response

• GMFCS III-V with generalized spasticity
• Adequate trunk control for seating/positioning
• No contraindications (active infection, anticoagulation, spinal anomalies)

• Reduces spasticity in all four extremities
• Improved posture, ease of caregiving, comfort
• Benefit maintained over 10 years without diminishment (Albright et al., 2003)
• Also beneficial for dystonia in some patients (reduces dystonia, improves posture)

• Catheter disconnection: 9% of implanted pumps
• Catheter dislodgement from intrathecal space: 8%
• Infection: 9.3%
• CSF leak: 4.9%
• Pump malfunction: 1%
• Overdose (rare): flaccid paralysis, respiratory depression, coma - emergency
• Withdrawal/underdose: Rebound spasticity, hyperthermia, seizures, rhabdomyolysis - life-threatening emergency

• ITB can reduce dystonia in some patients with mixed spasticity-dystonia
• ITB may worsen isolated dystonia in some cases
• Per the 2024 AACPDM guideline update: ITB is favoured for mixed dystonia + spasticity; DBS favoured for mixed dystonia + choreoathetosis

---

II. MANAGEMENT OF DYSTONIA

A. Oral/Enteral Agents for Dystonia

B. Botulinum Toxin A for Focal Dystonia

• Injections into specific dystonic muscles causing pain, interference with function, or positioning difficulty
• Useful for cervical dystonia (sternocleidomastoid, splenius capitis)
• Hip adductor dystonia causing scissoring or pain
• Repeated every 3-6 months per 2024 AACPDM guideline

C. Intrathecal Baclofen (ITB) for Dystonia

• Consider for severe generalized dystonia unresponsive to oral agents
• As above: ITB favoured when dystonia is mixed with spasticity
• Response less predictable than for spasticity

D. Deep Brain Stimulation (DBS) for Dystonia

---

III. MANAGEMENT OF EPILEPSY

Antiepileptic Drug (AED) Selection by Seizure Type

• Levetiracetam is commonly favoured (broad spectrum, minimal drug interactions, IV formulation available)
• Valproate: Highly effective but avoid in girls of childbearing age (teratogenicity); monitor LFTs and FBC; can increase risk of bleeding
• Carbamazepine/Oxcarbazepine: Avoid in generalized epilepsies (may worsen absence/myoclonic); good for focal
• Drug interactions: AEDs interact with each other and with antispasmodics; monitor
• Bone health: Long-term enzyme-inducing AEDs (phenytoin, carbamazepine, phenobarbital) reduce Vit D and bone mineral density → supplement Vit D + calcium
• Ketogenic diet: Effective for refractory epilepsy in CP (also benefits GLUT-1 deficiency if present)
• Vagus Nerve Stimulation (VNS): Adjunctive device for drug-refractory epilepsy; reduces seizure frequency by 50% in ~50% of patients; well tolerated

---

IV. MANAGEMENT OF PAIN

---

V. MANAGEMENT OF FEEDING AND NUTRITION

Causes

• Oromotor dysfunction (pharyngeal dysphagia, poor tongue control)
• GERD (gastro-oesophageal reflux disease)
• Constipation causing early satiety
• Spasticity and positioning difficulties
• High energy expenditure vs. poor intake

Medical Management

---

VI. MANAGEMENT OF DROOLING (SIALORRHOEA)

---

VII. MANAGEMENT OF BLADDER AND BOWEL

Neurogenic Bladder

• Symptoms: urgency, frequency, incontinence, retention, recurrent UTI
• Anticholinergics: Oxybutynin, tolterodine, solifenacin - reduce detrusor overactivity
• Alpha-blockers (tamsulosin): If bladder outlet obstruction/retention
• Mirabegron (Beta-3 agonist): Alternative to anticholinergics; fewer cognitive side effects
• Clean intermittent catheterisation (CIC): If incomplete bladder emptying
• Intravesical BoNT-A: For refractory detrusor overactivity

Constipation

• Nearly universal in GMFCS III-V CP
• Polyethylene glycol (Movicol/Miralax): First-line laxative
• Lactulose: Osmotic laxative; particularly in young children
• Stimulant laxatives (bisacodyl, senna): Second-line
• Docusate: Stool softener
• Suppositories/enemas: For impaction; bowel care programs
• Regular toileting schedule; adequate fluid and fibre intake

---

VIII. MANAGEMENT OF SLEEP DISORDERS

Causes

• Pain (spasticity, hip, GI)
• Epileptic seizures
• Sleep-disordered breathing (OSA, central apnoea)
• Reflux
• Neuroirritability and CNS dysregulation
• Medication side effects

Management

---

IX. MANAGEMENT OF RESPIRATORY COMPLICATIONS

• Aspiration pneumonia: Commonest cause of respiratory morbidity and mortality in CP
  • Prevention: optimize feeding safety (VFSS-guided), acid suppression for GERD, upright positioning, oral hygiene
  • Treatment: antibiotic therapy guided by culture (commonly Streptococcus pneumoniae, H. influenzae, anaerobes)
  • Annual influenza vaccine + pneumococcal vaccine recommended
• Restrictive lung disease (scoliosis, chest wall deformity):
  • TLSO bracing for scoliosis; surgical correction in severe cases
  • Chest physiotherapy; positive pressure devices (Flutter valve, Acapella)
  • NIV (BiPAP) for respiratory failure
• Secretion management: Hypertonic saline nebulization, suction, cough assist device (mechanical insufflator-exsufflator) for non-ambulatory CP

---

X. MANAGEMENT OF BONE HEALTH

• Osteopenia/osteoporosis present in >50% of non-ambulatory CP
• Risk factors: non-weight-bearing, Vitamin D deficiency, poor nutrition, enzyme-inducing AEDs (carbamazepine, phenytoin, phenobarbital deplete Vit D)
• Fracture risk significantly increased, especially distal femur and proximal humerus

---

XI. MANAGEMENT OF VISION PROBLEMS

• Strabismus (~40%): Glasses (spectacle correction); patching of dominant eye; botulinum toxin injection into extraocular muscles (Botox); strabismus surgery
• Refractive errors: Corrective lenses
• Cortical Visual Impairment (CVI): Environmental adaptations (high contrast materials, reduce visual clutter, use of preferred visual field); functional vision training
• Nystagmus: Prism glasses; rarely surgical (Kestenbaum procedure)

---

XII. MANAGEMENT OF COMMUNICATION AND COGNITIVE IMPAIRMENT

---

XIII. THERAPEUTIC HYPOTHERMIA (Neonatal Neuroprotection)

• Indication: Moderate-to-severe HIE at term gestation; initiated within 6 hours of birth
• Protocol: Whole body cooling to 33-34°C for 72 hours; then slow rewarming over 6-12 hours
• Mechanism: Reduces secondary neuronal injury phase → reduces apoptosis, excitotoxicity, free radical injury
• Evidence: Reduces death or major disability by ~25-30% in moderate HIE (Shankaran et al.)
• Add-on neuroprotection: Erythropoietin, melatonin, stem cells - investigational

---

XIV. EMERGING AND INVESTIGATIONAL TREATMENTS

---

SUMMARY: Treatment by CP Subtype

---

• Bradley and Daroff's Neurology in Clinical Practice - Chapter 111 (Cerebral Palsy)
• Goodman & Gilman's The Pharmacological Basis of Therapeutics
• Katzung's Basic and Clinical Pharmacology 16th Edition
• Pfenninger and Fowler's Procedures for Primary Care - Botulinum Toxin
• AACPDM Care Pathways: Pharmacological and Neurosurgical Management of CP and Dystonia - Clinical Practice Guideline Update, April 2024 (Fehlings et al., Dev Med Child Neurol 2024)
• NICE Guideline NG62: Cerebral Palsy in Under 25s - Last reviewed September 2024
• Royal Children's Hospital Clinical Practice Guidelines: Cerebral Palsy

---

Cerebral Palsy - Physiotherapy Assessment and Treatment in Detail

---

PART A: PHYSIOTHERAPY ASSESSMENT

---

1. FRAMEWORK AND PRINCIPLES

---

2. SUBJECTIVE ASSESSMENT (History-Taking)

From the Child and Caregiver

• Gestational age at birth, birth weight
• Perinatal events: HIE, IVH, PVL, sepsis, kernicterus
• Neonatal course: NICU admission, ventilation, seizures, hyperbilirubinemia
• Current medications (antispasmodics, AEDs, ITB pump details)
• Recent BoNT-A injections (date, muscles injected, response)
• Orthopaedic surgery history (dates, procedures, post-op course)
• SDR or ITB pump in situ

• Age of achieving motor milestones (rolling, sitting, crawling, standing, walking)
• Rate of developmental acquisition: continuous progress, plateau, or regression
• If regression noted → red flag for progressive condition

• Mobility: does child walk? With or without aid? Distance covered?
• Falls frequency and pattern
• Pain: site, severity (age-appropriate scale), aggravating/relieving factors
• Fatigue: activity tolerance, time to tire
• Sleep: quality, position, comfort
• School participation and physical education involvement
• Home environment: stairs, bathing, dressing independence

• Child's own goals (where age-appropriate)
• Family/caregiver goals
• Use Goal Attainment Scaling (GAS) to set measurable, individualized goals

---

3. OBJECTIVE ASSESSMENT - SYSTEMATIC FRAMEWORK

3A. OBSERVATION AND POSTURE

• Head position (forward head, torticollis)
• Spinal alignment: scoliosis, kyphosis, hyperlordosis
• Pelvis: anterior/posterior tilt, obliquity
• Hips: flexion, adduction, internal rotation posturing
• Knees: flexion/hyperextension, genu valgum/varum
• Feet/ankles: equinus, planovalgus, cavovarus, hindfoot varus

• Trunk control: independent sitting, propped, or dependent
• Pelvic position in sitting: posterior tilt, windswept
• Head control and alignment

• Resting limb posture
• Asymmetry suggestive of hemiplegia (fisting, arm posturing)

---

3B. PRIMITIVE REFLEX ASSESSMENT (Infants and Young Children)

• Righting reactions (head righting, body-on-body righting): Should develop from 4-6 months
• Equilibrium/balance reactions (tilting reactions): 6-18 months
• Protective extension (parachute): Forward (6m), Lateral (7m), Backward (9-10m)
  • Absent or asymmetric protective extension is an early sign of hemiplegia

---

3C. TONE ASSESSMENT

i. Modified Ashworth Scale (MAS)

• Simple, quick, widely used
• Limitation: Does not distinguish spasticity from contracture; not velocity-sensitive

ii. Modified Tardieu Scale (MTS) - Preferred for Spasticity

• R2 = Full passive ROM achieved at V1 (slow velocity) = true muscle extensibility
• R1 = Angle of "catch" (spastic response) at V2 or V3 (fast velocity)
• Spasticity Angle = R2 - R1

• Upper limb: seated
• Lower limb: supine
• Goniometer used to record all angles

iii. Hypertonia Assessment Tool (HAT)

• Spasticity: Velocity-dependent resistance; clasp-knife quality
• Dystonia: Involuntary, sustained or fluctuating muscle contractions; posturing
• Rigidity: Lead-pipe or cogwheel resistance; velocity-independent; both directions

---

3D. SELECTIVE MOTOR CONTROL ASSESSMENT

Selective Control Assessment of the Lower Extremity (SCALE)

• Maximum score = 20 (10 per limb)
• Highly correlated with GMFCS level and gait quality

---

3E. RANGE OF MOTION (ROM) ASSESSMENT

• Shoulder: flexion, abduction, internal/external rotation
• Elbow: flexion/extension, pronation/supination (pronation contracture common)
• Wrist: extension/flexion
• Finger: extension/flexion; thumb-in-palm deformity assessment

---

3F. MUSCLE STRENGTH ASSESSMENT

• Manual Muscle Testing (MMT) using Medical Research Council (MRC) scale (0-5)
• Note: Standard MMT may underestimate true strength due to spasticity making testing difficult
• Hand-held dynamometry (HHD): More objective and quantitative; measures force in Newtons/kg

• Hip extensors (gluteus maximus): Weak in all types
• Hip abductors (gluteus medius): Weak → Trendelenburg gait
• Knee extensors (quadriceps): Weak → crouch gait
• Ankle dorsiflexors (tibialis anterior): Weak → equinus/drop foot
• Core/trunk stabilizers: Often significantly impaired

---

3G. GAIT ASSESSMENT

Observational Gait Assessment

• 17-item scale; 6-point rating for each item
• Systematic video-based gait analysis (captures from front, side, back)
• Reliable for use in clinical practice without instrumented lab

• Standardized scale using slow-motion video analysis
• Assesses foot contact, stance phase, swing phase mechanics

Common Abnormal Gait Patterns in Spastic CP

3D Instrumented Gait Analysis (IGA)

• Gold standard for surgical planning and evaluation of interventions
• Captures: Kinematics (joint angles), Kinetics (moments, powers), EMG, energy expenditure
• Gait Deviation Index (GDI) or Gillette Gait Index (GGI): Single composite score of gait quality
• Indicates which muscles are overactive/underactive at each gait phase
• Required before multi-level orthopaedic surgery or SDR
• Age requirement: typically >4-5 years for reliable data

---

3H. FUNCTIONAL MOTOR ASSESSMENT - STANDARDIZED TOOLS

1. Gross Motor Function Measure (GMFM-88 and GMFM-66)

• Scored 0-3 per item: 0 = does not initiate; 1 = initiates (<10%); 2 = partially completes (10-<100%); 3 = completes (100%)
• Reliable across raters (ICC >0.99 for total score)
• GMFM-66 advantage: Can generate Gross Motor Ability Estimator (GMAE) score to predict motor development trajectory

2. Gross Motor Function Classification System (GMFCS)

• Already covered; use at every assessment to track functional level
• Should remain stable after age 2; if changes, investigate for progressive condition or secondary deterioration

3. Pediatric Evaluation of Disability Inventory (PEDI)

• Self-care, mobility, social function domains
• Measures functional capability vs performance
• Ages 6 months - 7.5 years (normative); older if CP-specific norms used

4. Functional Mobility Scale (FMS)

• Rates walking ability over three distances: 5m, 50m, 500m
• Each rated 1-6: 1 = uses wheelchair; 6 = independent on all surfaces
• Captures variability across environments (home vs. school vs. community)

5. Timed Tests

6. Pediatric Balance Scale (PBS)

• Adapted Berg Balance Scale for children with mild-moderate motor impairment
• 14 items; 0-4 scale; maximum 56
• Ages 5-15 years

---

3I. UPPER LIMB ASSESSMENT (Hemiplegia)

---

3J. PAIN ASSESSMENT

---

PART B: PHYSIOTHERAPY TREATMENT

---

4. GOALS OF PHYSIOTHERAPY

• Improve specific motor skills targeted at the child's functional priorities
• Improve ROM and prevent contracture formation
• Reduce pain
• Optimize positioning comfort

• Maximize independent mobility and functional participation
• Prevent secondary musculoskeletal complications (contractures, hip dislocation, scoliosis)
• Support transition through developmental stages (school, adolescence, adulthood)
• Caregiver education and empowered home program

---

5. EVIDENCE SUMMARY FOR PT INTERVENTIONS

"Intensive activity-based, goal-directed interventions are more effective. The ability of manual stretching to increase ROM and reduce spasticity is limited. NDT has low-quality evidence." - Das and Ganesh, Evidence-Based Approach to Physical Therapy in CP, Indian J Orthop 2019

---

6. TREATMENT INTERVENTIONS IN DETAIL

---

6A. GOAL-DIRECTED / FUNCTIONAL TRAINING

• Child and family set meaningful, achievable functional goals (e.g., "walk to the school bus independently," "kick a ball")
• High repetition of specific tasks drives neuroplasticity in the developing brain
• Practice in natural environments (home, school, playground) - not just therapy room
• Intensity matters: Higher dose (more repetitions, more sessions) = better outcomes
• SMART goals: Specific, Measurable, Achievable, Relevant, Time-bound
• Goal Attainment Scaling (GAS): Individualized goal measurement; each goal scaled -2 to +2

---

6B. NEURODEVELOPMENTAL TREATMENT (NDT) / BOBATH APPROACH

• Inhibit abnormal movement patterns and tone through key points of control
• Facilitate normal automatic movement patterns and postural reactions
• Focus on sensorimotor experience to drive motor learning
• Handling techniques: rotation, weight-bearing, weight-shifting

• Not superior to other approaches as a standalone treatment (multiple systematic reviews, Cochrane)
• Cheshire & Merseyside NHS (March 2024): "Bobath therapy is not routinely commissioned for children with CP - superiority over other approaches not proven"
• May demonstrate tendency toward effectiveness across all ICF levels but results are inconsistent
• Current role: Elements incorporated within a broader functional, goal-directed treatment approach rather than as a standalone philosophy

---

6C. STRETCHING PROGRAMS

Passive Stretching

• Daily passive stretching of spastic/shortened muscle groups
• Evidence: Limited long-term benefit for reducing spasticity or preventing contracture as sole treatment
• Best used as part of a broader program

• Gastrocnemius/soleus: Ankle dorsiflexion stretching
• Hamstrings: Straight-leg raise stretching, long-sitting position
• Hip flexors (iliopsoas): Thomas test position stretching, prone lying
• Hip adductors: Abduction stretching, frog-leg position
• Tensor fascia latae/IT band: Side-lying stretching

• Pronators: Supination stretching
• Wrist/finger flexors: Wrist/finger extension
• Elbow flexors: Extension stretching
• Thumb adductor/thumb-in-palm: Abduction stretching

• Prolonged low-load stretch (>30 minutes) more effective than brief passive stretch
• Best incorporated through positioning (prone lying, standing frames, night splints)
• Combine with AFO wear and casting for maximal effect
• Should be taught to caregivers for daily home program

Serial Casting

• Indication: Fixed equinus, knee flexion contracture, wrist/elbow flexion contracture
• Progressive plaster or fibreglass casts applied serially (changed every 5-7 days for 4-6 weeks)
• Low-load prolonged stretch over time → gradual elongation of soft tissue
• Most effective when combined with BoNT-A injection 2-4 weeks prior (reduces tone, allows better stretch)
• Post-casting: AFO fabricated to maintain gains
• Contraindications: Open wounds, skin fragility, sensory loss, severe osteoporosis

---

6D. STRENGTHENING PROGRAMS

• Target both spastic agonist muscles and weak antagonist muscles
• Focus particularly on: hip extensors, hip abductors, quadriceps, ankle dorsiflexors, core
• Progressive overload: increase resistance/repetitions as strength improves
• Functional strengthening preferred: sit-to-stand, step-ups, stair climbing
• Combines with gait training and task-specific practice

• Resistance bands
• Free weights and bodyweight
• Functional task training (stair climbing, sit-to-stand repetitions)
• Isokinetic dynamometry training
• Hydrotherapy resistance
• Cycle ergometer training

---

6E. CONSTRAINT-INDUCED MOVEMENT THERAPY (CIMT)

• Constrains the unaffected hand using a cast, glove, or splint for 6-8 hours/day
• Forces intensive practice with the affected hand through structured repetitive tasks
• Harnesses activity-dependent cortical reorganization (neuroplasticity)
• Based on learned non-use theory: child avoids using affected limb due to initial failure; CIMT reverses this

• Spontaneous use of affected hand (AHA scores)
• Upper limb quality of movement (MA2)
• GMFM dimension B and E
• Parental reports of hand use in daily life

• Alternative to CIMT; structured practice of bimanual tasks without constraint
• Equal evidence to CIMT for improving bimanual coordination
• More ecologically valid for daily activities requiring both hands

---

6F. GAIT TRAINING

Overground Gait Training

• Task-specific practice of walking in different environments
• Obstacle courses, varied terrains, direction changes
• Graded assistance: parallel bars → rollator → single stick → unaided
• Combined with AFO wearing and orthotic management

Treadmill Training

• Improves gait speed, cadence, and step length
• Suitable for GMFCS I-III ambulatory CP
• Combine with overground practice for best results

• Body weight supported via overhead harness (10-40% bodyweight unloaded)
• Facilitates repetitive gait cycle practice with improved safety and reduced fear
• Suitable for lower functioning ambulatory children (GMFCS II-III)
• 2024 systematic review (Alotaibi et al.): PBWSTT significantly improves walking speed, GMFM scores, and stride length in children and adolescents with CP

• Computerized exoskeleton guides lower limbs through repeated gait patterns on a treadmill
• High repetition volume; programmable assistance levels
• Motivating for children; gamified feedback
• Evidence: Improves gait kinematics and GMFM scores; not superior to manual PBWSTT for speed gains but provides high volume and motivation
• Suitable for non-ambulatory and low-ambulatory CP (GMFCS III-IV)

---

6G. BALANCE AND POSTURAL CONTROL TRAINING

• Exercise-based balance training: Progressive balance challenges on stable → unstable surfaces
• Perturbation training: Unexpected platform tilts, pushes
• Standing frame programs: Passive weight-bearing through standing frames for non-ambulatory children; improves bone density, hip alignment, tone, and bowel function; recommended 30-60 min/day
• Proprioceptive training: Wobble boards, balance discs, single-leg standing challenges
• Virtual Reality (VR) / Exergaming: Wii Fit balance board, Nintendo Switch; improves balance outcomes and provides high motivation; evidence growing

---

6H. POSTURAL MANAGEMENT - 24-HOUR APPROACH

---

6I. ORTHOTIC MANAGEMENT

Lower Limb Orthoses

Upper Limb Orthoses

---

6J. AQUATIC THERAPY (HYDROTHERAPY)

• Facilitates movement in children with high tone
• Reduces pain during exercise
• Improves ROM, strength, cardiovascular fitness
• Reduces fear (water support allows safe exploration of movement)
• Motivating; social benefits

• Halliwick concept (water confidence → independence)
• Bad Ragaz ring method (resistance and facilitation in water)
• Walking in water (resistance gait training)
• Swimming (bilateral coordination; trunk stabilization)

---

6K. ELECTRICAL STIMULATION

Neuromuscular Electrical Stimulation (NMES)

• Electrical stimulation to stimulate weak muscles (tibialis anterior for foot drop, quadriceps for crouch gait)
• Causes muscle contraction; improves strength and voluntary recruitment
• Best combined with functional tasks during stimulation

Functional Electrical Stimulation (FES)

• Surface electrodes trigger muscle contraction during gait cycle at correct timing
• e.g., FES for dorsiflexion in swing phase of gait (footdrop)
• Odstock dropped foot stimulator: Most researched FES device for foot drop
• Improves gait speed and cadence; requires adequate selective motor control

Transcutaneous Electrical Nerve Stimulation (TENS)

• Pain management: analgesia via gate control mechanism
• No muscle contraction; purely analgesic

---

6L. HIPPOTHERAPY AND THERAPEUTIC HORSE-RIDING

• Trunk control and postural stability
• Balance reactions
• Hip ROM (adductor stretch in horse-riding position)
• Motivation and engagement; psychological wellbeing

---

6M. WHOLE BODY VIBRATION (WBV)

• Child stands on vibrating platform (25-50 Hz); passive stimulation of muscle spindles and proprioceptors
• Proposed: increases lower limb muscle activity, reduces spasticity short-term, improves bone density
• Evidence: Low-level; some positive short-term effects on spasticity and GMFM; needs larger RCTs

---

6N. VIRTUAL REALITY AND TECHNOLOGY-AIDED THERAPY

• Commercial systems: Nintendo Switch, Wii Fit, Xbox Kinect
• Clinical VR: Immersive headsets; haptic feedback devices
• Benefits: High motivation and engagement; high repetition volume; real-time feedback; suitable for home use
• Evidence: Moderate; improves balance, cadence, and selected gait outcomes; does not replace task-oriented gait training but complements it

---

6O. RESPIRATORY PHYSIOTHERAPY

• Airway clearance techniques: Active Cycle of Breathing (ACBT), postural drainage, percussion, vibration
• Cough augmentation: Mechanical Insufflator-Exsufflator (MI-E / CoughAssist) for children with poor cough
• Positioning: Optimize for secretion drainage; elevate head of bed for GERD
• Incentive spirometry: For those who can cooperate
• Exercise training: Improves aerobic capacity and respiratory muscle strength

---

6P. POST-BOTULINUM TOXIN AND POST-SURGICAL PHYSIOTHERAPY

• Maximise benefit window (peak effect 4-6 weeks)
• Intensive stretching, strengthening, gait training, casting
• Practice of functional skills: climbing stairs, kicking ball, writing
• AFO refitting if equinus reduced

• Phase 1 (0-6 weeks): Pain management, gentle ROM, wound care, preventing complications
• Phase 2 (6-12 weeks): Progressive ROM, early weight-bearing as per surgeon protocol
• Phase 3 (3-6 months): Strengthening, gait re-education, functional training
• Phase 4 (6+ months): Return to sport/school activities; stair training; community mobility

• Intensive post-operative physiotherapy is essential for SDR outcomes
• Phase 1 (2-8 weeks): ROM, gentle muscle activation, prevent contracture
• Phase 2 (2-6 months): Intensive strengthening (gluteals, quads, dorsiflexors), gait re-education
• Phase 3 (6-24 months): Ongoing intensive physiotherapy - 1-2 sessions/day for 1-2 years
• Cognition and cooperation critical for SDR rehabilitation success

---

7. TREATMENT BY GMFCS LEVEL

---

8. HOME PROGRAM AND CAREGIVER EDUCATION

• Daily stretching routine: 10-20 minutes, targeting key tight muscles; demonstrate correct technique
• Positioning schedule: Prone lying, standing frame times, nighttime sleep system
• Orthotic wearing schedule: AFO/splint on/off times; skin check instructions
• Functional activities: Carrying out ADLs in a way that promotes movement goals (e.g., reaching for objects, kicking a ball in garden)
• Strengthening activities: Sit-to-stand practice, stair climbing, playground equipment
• Written home program: Photos/video demonstrations; appropriate language for family's literacy level
• Review and progression: Every 6-12 weeks; update as child progresses

---

9. MONITORING AND OUTCOME MEASUREMENT

---

• Bradley and Daroff's Neurology in Clinical Practice - Chapter 111
• Campbell's Operative Orthopaedics 15th Edition 2026
• Das & Ganesh, Evidence-Based Approach to Physical Therapy in CP - Indian J Orthop 2019 (PMC6394183)
• Alotaibi et al., Effectiveness of PBWSTT in CP: Systematic Review and Meta-Analysis - Children 2024
• Strokengine / RehabMeasures: Modified Tardieu Scale
• Cheshire & Merseyside NHS: Bobath/NDT Policy Statement - March 2024
• Springer Nature Bratislava Medical Journal: Evidence and Practice in Rehabilitation of CP - 2026
• AACPDM Care Pathways: Dystonia in CP - 2024

---

Cerebral Palsy - Physiotherapy Management (Complete)

---

PART 1: PRINCIPLES AND FRAMEWORK

Overarching Goal

Core Principles (Evidence-Based)

1. Intensity matters - high-repetition, high-dose practice produces greater neuroplastic change than low-dose therapy
2. Goal-directed over impairment-directed - training toward meaningful, child/family goals outperforms passive stretching and impairment-focused treatment
3. Task specificity - the skill you practice is the skill that improves; transfer is limited
4. Neuroplasticity window - the developing brain responds more robustly to rehabilitation; early intervention and intensive periods are prioritized
5. 24-hour approach - tone, positioning, and function must be addressed across the entire day, not just in sessions
6. Family as primary therapists - carryover into daily life requires trained, confident families
7. ICF framework - address body structure, activity, and participation simultaneously, not sequentially

Evidence-Based Decision Tool: Novak Traffic Light System (2019/2020)

---

PART 2: EVIDENCE CLASSIFICATION OF PT INTERVENTIONS

🟢 GREEN LIGHT - Recommended (Do It)

🟡 YELLOW LIGHT - Measure Outcomes (Use with Monitoring)

🔴 RED LIGHT - Do Not Do

---

PART 3: PT MANAGEMENT APPROACHES IN DETAIL

---

3.1 NEURODEVELOPMENTAL TREATMENT (NDT) / BOBATH APPROACH

• Abnormal tone, persistent primitive reflexes, and absent postural reactions underlie disordered movement
• Through specific handling techniques at key points of control, abnormal patterns are inhibited and normal movement patterns are facilitated
• Normalizing sensorimotor experience drives cortical reorganization

• Inhibition: Reducing abnormal tone and primitive reflex patterns (e.g., using reflex inhibiting postures - RIPs)
• Facilitation: Guiding the child through normal movement experiences using therapist's hands
• Key points of control: Proximal (shoulder girdle, pelvis) or distal (hands, feet) points through which tone and movement can be influenced
• Postural reactions: Righting, equilibrium, and protective reactions are trained through handling
• Carry-over: Techniques taught to parents and caregivers for application throughout the day

• Trunk rotation and weight-shifting in sitting to inhibit extensor spasticity and facilitate postural reactions
• Controlled weight-bearing through upper limbs (prone propping, 4-point kneeling) to normalize proximal tone
• Placing and reaching activities with controlled key point handling
• Facilitated stepping on treadmill or overground using hip/pelvis key points
• Bridging (supine hip extension) to activate gluteals and inhibit hip flexor spasticity
• Sitting balance activities with perturbation to train equilibrium reactions

• NDT was widely considered the gold-standard for decades
• Current evidence: NOT superior to other approaches; placed at 🟡 yellow light
• 2024 Damiano & Novak (Dev Med Child Neurol): "NDT/Bobath requires rebranding versus rigor - clinical science must prevail"
• Appropriate use: Elements of NDT handling can be incorporated within goal-directed and task-specific frameworks; should NOT be the sole philosophy
• Still included in standard care in many countries; valuable for therapist reasoning and movement analysis

---

3.2 PROPRIOCEPTIVE NEUROMUSCULAR FACILITATION (PNF)

• Uses diagonal, spiral movement patterns that mirror functional human movement
• Proprioceptive input from muscles and joints facilitates motor neuron pools
• Stimulates normal reciprocal muscle activation

---

3.3 VOJTA THERAPY (REFLEX LOCOMOTION)

• Applies pressure to defined trigger zones on the body in specific positions (prone, supine, side-lying)
• Elicits two automatic reflex movement complexes:
  • Reflex creeping (from prone): activates total body coordination in a locomotion pattern
  • Reflex rolling (from supine/side-lying): coordinates trunk, limbs, and eyes in a rolling pattern
• Repeated stimulation strengthens previously blocked neurological pathways between spinal cord and brain
• Does not require conscious cooperation → suitable for infants and children with severe cognitive impairment

• Located on chest, heel, knee, elbow, shoulder, and other defined anatomical landmarks
• Therapist applies pressure and resistance to current movement direction → automatic movement response

1. Position child in prescribed starting position (prone/supine/side-lying)
2. Locate and activate trigger zones
3. Maintain resistance to the spontaneous movement pattern that occurs
4. Session: 4 x/day for 5-20 minutes each (often home-based after training of parents)

• Activation of dormant postural reflex mechanisms
• Improved muscle co-activation and reciprocal inhibition
• Better head control, trunk stability, and limb coordination
• Improved breathing, swallowing, and speech coordination

• Post-surgical Vojta protocol (2024): improved functional outcomes after orthopedic surgery in CP

---

3.4 GOAL-DIRECTED TRAINING (GDT)

• Child and family set meaningful, personally relevant goals (e.g., "I want to ride a bicycle," "I want to dress myself")
• Therapy sessions are specifically designed to practice sub-skills needed for that goal
• High-intensity repetition in ecologically relevant contexts (home, school, playground)
• Uses Goal Attainment Scaling (GAS) to set, monitor, and evaluate goals

• Each goal scaled from -2 to +2:
  • -2: Baseline performance (current level)
  • -1: Less than expected change
  • 0: Expected level of achievement
  • +1: Somewhat more than expected
  • +2: Much more than expected
• Allows individualized, meaningful measurement across all levels

"In 8 weeks, [child's name] will walk from the classroom to the school canteen (50m) using rollator walker independently, without adult assistance, on 3 out of 5 days"

---

3.5 TASK-SPECIFIC TRAINING

Sit-to-Stand Training

• High repetition (50-100 per session) from different seat heights
• Improves quadriceps strength, hip extensor power, balance
• Translates directly to independence in ADLs
• Progress: normal height chair → low chair → floor transfers

Stair Training

• Step up/down practice; reciprocal vs. marking time strategies
• Handrail → no handrail progression
• Step height, pace, and load progression

Stepping and Walking Tasks

• Obstacle courses; varied terrain surfaces
• Direction changes; stepping over objects
• Dual-task walking (carrying object while walking)

Reaching and Grasping (Upper Limb)

• Functional reaching in all directions and ranges
• Object manipulation: stacking, pouring, unscrewing, cutting
• ADL-embedded: dressing, feeding, grooming tasks

---

3.6 STRENGTHENING PROGRAMS

• Progressive overload: increase resistance 5-10% when 3 sets of 10 can be completed with good form
• 3 sets x 8-12 repetitions, 3-5 days/week
• Rest 48 hours between sessions for same muscle group
• Combine with functional tasks to maximize transfer
• Use: resistance bands, body weight, free weights, isokinetic equipment, aquatic resistance

---

3.7 STRETCHING AND FLEXIBILITY PROGRAMS

Passive Stretching

• Therapist or caregiver manually moves limb to end range and holds
• Duration: minimum 20-30 seconds; repeated 3-5 times
• Frequency: 2x daily minimum
• Evidence: Limited long-term benefit when used alone; maintains range but does not reduce spasticity or prevent contracture independently

Prolonged Positioning Stretch (Most Effective)

• Maintains tissue at elongated length for extended periods (>30 min/day)
• Achieved through: AFO wearing, night splints, prone lying, standing frame, serial casting
• Evidence: Prolonged stretch > brief passive stretch for preventing contracture

Hold-Relax Stretching (PNF-based)

• 6-10 second isometric contraction of the tight muscle → relax → passively lengthen
• Autogenic inhibition via Golgi Tendon Organ (GTO) feedback
• Gains slightly more ROM than passive stretching

Active Stretching

• Child actively shortens antagonist to achieve reciprocal inhibition of tight muscle
• e.g., active ankle dorsiflexion to inhibit gastrocnemius spasticity

---

3.8 SERIAL CASTING

• Fixed equinus deformity (most common)
• Knee flexion contracture
• Elbow/wrist flexion contracture
• Best timing: 2-4 weeks AFTER BoNT-A injection, when tone is reduced → casting captures greater ROM

---

3.9 CONSTRAINT-INDUCED MOVEMENT THERAPY (CIMT)

• Children with hemiplegia develop learned non-use of the affected limb due to repeated failures → compensatory use of unaffected hand
• CIMT reverses this by constraining the unaffected hand and intensively practicing with the affected hand
• Drives neuroplasticity in the lesioned hemisphere's motor cortex

1. Successive approximation (shaping): Tasks graded from easy → difficult
2. Repetitive practice: 100-300 repetitions per session
3. Child-driven selection: child chooses activities within the structured framework
4. Real-world tasks: writing, cutting, buttoning, stacking, throwing, catching
5. Bimanual integration: towards end of program, incorporate both hands together

• Parent-delivered with remote/in-person coaching from OT/PT
• Sock/splint on unaffected hand for short periods daily
• Parent guides reaching, grasping, and exploration with affected hand
• 2024 study (Svensson et al.): baby-mCIMT delivered via telerehabilitation as effective as in-person coaching

---

3.10 BIMANUAL THERAPY (HABIT - Hand-Arm Bimanual Intensive Therapy)

• No constraint used
• Both hands practice together in structured bimanual tasks
• More ecologically valid (most real-life tasks are bimanual)

• 60-90 hours total over 2-3 weeks
• Play-based: stacking, cutting, drawing, cooking, sport activities requiring both hands
• Outcomes (Chaudhari & Satralkar 2024): Gains in WeeFIM and BOT-2 maintained up to 6 months; periodic repeats recommended

---

3.11 GAIT TRAINING

A. Overground Gait Training

• Direct, task-specific walking practice
• Parallel bars → walker → crutches → unaided progression
• Varied surfaces: carpet, grass, ramps, stairs
• Obstacle negotiation, dual-task walking (carrying object)
• Community reintegration walking (pavements, shops, school)
• Key principle: Practice walking to improve walking

B. Treadmill Training

• Set speed 10-30% faster than comfortable overground speed
• Provides rhythmic, consistent sensory input (proprioceptive, vestibular)
• External pacing supports rhythm maintenance
• Suitable GMFCS I-III
• Duration: 20-30 min/session; 3-5x/week
• Combine with overground practice for best transfer

C. Partial Body Weight-Supported Treadmill Training (PBWSTT)

• Overhead harness unloads 10-40% of body weight
• Allows repetitive stepping practice without fear of falling
• Suitable for GMFCS II-III (lower ambulatory function)
• Therapist can manually guide limb movement if needed
• 2024 Meta-analysis (Alotaibi et al., Children 2024): Significantly improves walking speed, GMFM, step length, and cadence in children and adolescents with CP

D. Robotic-Assisted Gait Training (Lokomat/Exoskeleton)

• Computerized exoskeleton attached to lower limbs
• Guides legs through precise gait patterns on treadmill
• Provides high repetition volume (1000-3000 steps/session)
• Real-time biofeedback; gamified for children
• Adjustable guidance force (0-100%)
• Suitable GMFCS II-IV
• Evidence: Improves gait kinematics, motivation, and practice volume; not superior to manual PBWSTT for speed

---

3.12 POSTURAL MANAGEMENT - 24-HOUR APPROACH

A. Prone Positioning

• Goal: Hip and knee extension; thoracic extension; counteract flexor dominance
• Duration: 30-60 min/day minimum
• Equipment: Prone wedge, bolster, therapy roll
• Precautions: Airway clearance; not appropriate post-gastrostomy until healed

B. Supine Positioning

• Goal: Symmetry; hip abduction to prevent windswept deformity
• Equipment: T-roll between knees/thighs; abductor wedge; neck roll for head

C. Sitting

• Symmetrical pelvic positioning is the foundation for all upper limb function
• Specialist seating system components:
  • Seat depth: 2-finger gap behind knee; prevents posterior pelvic tilt
  • Seat width: Just wider than pelvis; prevents scoliotic leaning
  • Foot support: Both feet flat; prevents hip rotation
  • Pelvic belt (at 45°): Anterior pelvic stabilization
  • Trunk laterals: Prevent scoliosis
  • Headrest: For those with poor head control
  • Tray: Upper limb support; activity platform
• Positioning principle: "Fix the pelvis, free the hands" - stable base enables upper limb function

D. Standing - Standing Frame Programs

• Reduces hip subluxation risk (weight-bearing through hip joint)
• Improves bone mineral density
• Reduces spasticity (prolonged weight-bearing input inhibits plantar flexors)
• Facilitates bowel function
• Enables eye-level communication
• Psychological and social benefits

E. Night Positioning

• Sleep system: Custom-moulded or sling-based system maintaining hip and spinal alignment during sleep
• Prevents windswept hip deformity (one hip adducted, one abducted) - a major contributor to hip dislocation
• Prevents shoulder/hip contracture from prolonged side-lying in flexion
• Review annually or more frequently with growth

---

3.13 ORTHOTIC MANAGEMENT

Lower Limb Orthoses

• Typically 8-12 hours/day during waking activity
• Remove for bathing, stretching sessions, swimming
• Skin checks at every removal - check for redness/pressure marks
• Replace every 6-12 months (faster in growing children)
• Compliance (Oestreich et al., Gait Posture 2025): Wearing time directly correlates with gait outcomes; compliance monitoring essential

Upper Limb Orthoses (Hemiplegia)

---

3.14 AQUATIC THERAPY (HYDROTHERAPY)

Halliwick Method (Aquatic Independence Framework)

• 10-point program from water adjustment → independent swimming
• Disengagement (separation from supports) → rotational control → balance → swimming strokes
• Suitable for all GMFCS levels; builds confidence and safety

Bad Ragaz Ring Method

• Rings support patient floating horizontally
• Therapist provides proprioceptive facilitation through PNF patterns in water
• Resistive and supportive patterns for upper/lower limb; trunk stability

Watsu (Water Shiatsu)

• Passive stretching and mobilisation in warm water
• Significant psychological wellbeing and spasticity reduction (Schitter et al., 2020)
• Suitable for severely affected CP; GMFCS IV-V

• GMFCS I-III: Active swimming; gait practice in water; resistance exercises
• GMFCS IV-V: Passive stretching in warmth; pain reduction; movement facilitation; positioning
• Water temperature: 34-36°C optimal for tone reduction

---

3.15 ELECTRICAL STIMULATION

A. Neuromuscular Electrical Stimulation (NMES)

• Surface electrodes over weak muscle (e.g., tibialis anterior for foot drop; quadriceps for crouch gait)
• Stimulates muscle contraction; increases voluntary motor unit recruitment over time
• Use during functional tasks for best transfer (active NMES)
• Parameters: 30-50 Hz; 200-300 µs pulse width; intensity to visible contraction

B. Functional Electrical Stimulation (FES)

• Timed stimulation synchronized with gait cycle
• Foot drop stimulator (Odstock/Bioness): triggers TA/peroneal group during swing phase
• Foot clearance improved; gait speed increases with use
• Orthotic effect (immediate) vs therapeutic effect (lasting after removal)
• Requires at least partial voluntary motor control and sensation

C. Transcutaneous Electrical Nerve Stimulation (TENS)

• Analgesia via gate-control mechanism
• No motor stimulation
• Pain management in hip pain, post-surgical pain, dystonia-related pain

---

3.16 CONDUCTIVE EDUCATION

• Group-based intensive learning program combining PT, OT, education, and psychology
• Uses slatted wooden plinth (plinths/ladder-back chairs) as apparatus for exercise sequences
• Child is guided through task sequences with rhythmic intentional speech ("I lift my arm - 1, 2, 3...")
• Conductor (specially trained educator-therapist) leads all sessions
• Group social dynamic motivates children
• Child learns to overcome neuromotor difficulties through active problem-solving

---

3.17 HIPPOTHERAPY

• Trunk postural control (erector spinae, abdominals)
• Hip abductor stretch (wide-based riding position)
• Equilibrium and righting reactions (horse's movement challenges balance)
• Lower limb coordination (weight-shifting in rhythm with horse)
• Reduced spasticity during and immediately after session

---

3.18 RESPIRATORY PHYSIOTHERAPY

---

PART 4: PHYSIOTHERAPY MANAGEMENT BY PHASE

Phase 1: Early Intervention (0-2 years)

• GAME Program (Goals, Activity, Motor Enrichment): Parent-led; motor training + environmental enrichment + coaching → better cognitive and motor outcomes at 1 year
• Vojta therapy: Activates reflex locomotion; suitable from birth
• NDT handling: Taught to parents for daily carry-over
• Baby-mCIMT (3-8 months): For identified early hemiplegia
• Prone time: Daily supervised; 15-30 min
• Parent coaching: Primary focus - build caregiver competence for daily application
• Frequency: 1-2 formal PT sessions/week; daily home program essential

---

Phase 2: Developmental Age 2-5 Years

• GDT: Age-appropriate goals (walking outdoors, play, dressing)
• Strengthening: Functional (sit-to-stand, stair climbing, play-based)
• AFO fitting: If equinus or planovalgus detected
• Standing frame: If not independently standing (GMFCS III-IV)
• BoNT-A + casting/PT: First injection cycles if spasticity is functional-limiting
• Powered mobility introduction (GMFCS IV-V): Early powered mobility supports cognitive and social development
• Frequency: 2-3 formal sessions/week; intensive blocks around BoNT-A

---

Phase 3: School Age (5-12 Years)

• Intensive therapy blocks: 2-4 week intensive programs (camp-based or clinic-based) > once/week maintenance
• CIMT/HABIT for hemiplegia (most evidence in this age group)
• Gait training: Treadmill, PBWSTT, overground; gait analysis before surgical decisions
• Serial casting: Annual casting cycles if equinus recurring
• Progressive strengthening: More formal resistance program
• School-based physiotherapy: Liaise with school staff; modifications for PE, mobility in school
• Hip surveillance: Per GMFCS protocol; communicate with orthopaedic team
• Pre/post BoNT-A intensive PT: Every 4-6 months per injection cycle
• Frequency: 1-2 formal sessions/week; 4-6 week intensive blocks 1-2x/year

---

Phase 4: Adolescence (12-18 Years)

• Critical growth spurt period: Rapid bone growth without equivalent muscle lengthening → worsening contractures and gait regression
• Intensive stretching and casting: More frequent during growth spurts
• Fitness training: Cardiovascular exercise; adapted sport; cycling; swimming
• Gait re-evaluation: Repeat 3D gait analysis; reassess orthotic/surgical needs
• Self-management training: Teach adolescent to manage own home program; transition toward autonomy
• Psychosocial support: Body image, peer relationships, sport inclusion
• Prepare for transition to adult services

---

Phase 5: Adulthood (18+ Years)

• Adults with CP experience accelerated musculoskeletal aging: increased pain, fatigue, joint degeneration earlier than general population
• Pain management PT: Joint mobilizations, manual therapy, exercise for back pain, hip pain
• Maintenance of ROM: Ongoing stretching; positioning as needed
• Fitness and health: Hydrotherapy, cycling, adapted sport to maintain cardiovascular health
• Community mobility optimization: Wheelchair provision, mobility aids, driving assessment
• Fatigue management: Energy conservation strategies; pacing; environmental adaptation
• Transition to adult teams: Maintain MDT input through adult rehabilitation services

---

PART 5: POST-OPERATIVE PHYSIOTHERAPY

After Botulinum Toxin A Injection

After Orthopaedic Surgery

After Selective Dorsal Rhizotomy (SDR)

---

PART 6: HOME PROGRAM AND CAREGIVER TRAINING

Components

Teaching Principles

• Demonstrate → guided practice → independent practice (teach-back method)
• Written + visual instructions; video demonstrations on parent's phone
• Build on each visit; don't overload with too many tasks at once
• Regular review and progression every 6-8 weeks

---

PART 7: SUMMARY TABLE - PT INTERVENTIONS BY GMFCS LEVEL

---

• Bradley and Daroff's Neurology in Clinical Practice - Chapter 111
• Novak I et al. "State of the Evidence Traffic Lights 2019: Systematic Review of Interventions for Preventing and Treating Children with Cerebral Palsy." Curr Neurol Neurosci Rep 2020;20(2):3. (PMID: 32086598) - the gold standard CP intervention evidence review
• Das & Ganesh, Evidence-Based Approach to Physical Therapy in CP - Indian J Orthop 2019 (PMC6394183)
• Javanian - Effective Physiotherapy Techniques for Children with CP, 2024
• Alotaibi et al. PBWSTT Meta-Analysis - Children 2024
• Sanchez-Gonzalez et al. Vojta Therapy Systematic Review - Front Neurol 2024 (PMC11070493)
• Conductive Education Systematic Review - PMC12312667, 2025
• Damiano & Novak, NDT/Bobath rebranding vs rigor - Dev Med Child Neurol 2024
• AACPDM Care Pathways, NICE NG62 CP Guidelines, RCH Melbourne CP Guidelines

---

Cerebral Palsy - Standard Physiotherapy Management and Detailed Treatment Plan

---

SECTION 1: STANDARD PT MANAGEMENT NOTES FORMAT

Standard Physiotherapy Notes Template for CP

---

---

A. PRESENTING PROBLEM

---

B. SUBJECTIVE (S)

• Type and distribution of CP (e.g., spastic diplegia)
• GMFCS level: ___
• Birth history: gestational age, birth complications, NICU admission
• MRI findings: ___
• Current medications: antispasmodics, AEDs, recent BoNT-A (date, muscles)

• Mobility: ambulant/non-ambulant, assistive device used
• Falls: frequency, circumstances
• Transfers: independent/assisted (floor-stand, bed-chair, car)
• ADL participation: dressing, feeding, bathing - level of assistance
• School participation and physical education

• Site: _____ | Character: _____ | Severity: ___/10 (FPS-R or NRS)
• Aggravating/relieving factors
• Impact on sleep and activity

1. Child's goal: _______________
2. Caregiver's goal: _______________

---

C. OBJECTIVE (O)

• Resting posture in standing/sitting
• Spinal alignment: scoliosis/kyphosis noted
• Limb posturing

• GMFM-66 score: ___
• 10MWT: ___m/s (comfortable) | ___m/s (fast)
• TUG: ___seconds
• FMS (5m/50m/500m): //___

• ATNR: Present/Absent
• Moro: Present/Absent
• Protective extension: Present/Absent/Asymmetric

---

D. ANALYSIS / PROBLEM LIST

1. ---

2. ---

3. ---

---

E. PLAN

1. ---

2. ---

1. ---

2. ---

---

SECTION 2: DETAILED TREATMENT PLANS BY CP TYPE

---

TREATMENT PLAN 1: SPASTIC DIPLEGIA (GMFCS II-III)

Case Scenario

Child: 7 years, male. Diagnosis: Spastic diplegia, GMFCS Level II. Born at 28 weeks; PVL on MRI. Walks independently indoors; uses rollator walker outdoors. Falls 3-4x/week. Equinus bilaterally, toe-walking gait, scissoring. Hip adductors tight. Wears bilateral hinged AFOs. Last BoNT-A to bilateral gastrocnemius 6 weeks ago.

---

PROBLEM LIST

---

GOALS

1. Improve ankle dorsiflexion ROM to ≥5° bilaterally with knee extended (currently 0°R, -2°L)
2. Improve gait speed to 0.75 m/s on 10MWT
3. Reduce falls to ≤1/week through improved balance and gait mechanics
4. Improve GMFM-66 score by ≥4 points
5. Child independently practices home stretching program daily with caregiver supervision

1. Walk independently (without rollator) for school hallway distances (50m) safely
2. Improve hip abductor strength to 4/5 bilaterally
3. Maintain equinus correction achieved via casting
4. Participate in school sports day with peer support

---

TREATMENT PROGRAM

Session Structure (Standard 45-60 min Session)

---

MODULE 1: TONE AND STRETCHING PROGRAM

• Child stands in lunge position facing wall, hands on wall
• Front foot flat on floor; rear leg straight (gastrocnemius) or bent (soleus)
• Lean forward until stretch felt in calf
• Hold 30-60 seconds; 3 repetitions each side
• Progress: increase stretch angle, progress to single-leg standing stretch

• Child stands on inclined stretching board (15-20° inclination)
• Heels on board, toes up; maintained for 20-30 minutes
• Can do activity (reading, iPad) during stretching
• Most effective form of gastrocnemius stretch for CP

• Therapist stabilises knee in extension
• Slowly dorsiflexes ankle to end range; holds 30 seconds
• 5 repetitions; alternate with active DF against resistance

---

• Child sits upright on floor, legs straight
• Hands on thighs; maintain neutral lumbar spine
• Lean forward from hips (NOT spine flexion) until hamstring stretch felt
• Hold 30 seconds; 3 repetitions

• Child supine; therapist flexes hip with knee extended to end range
• Hold 30 seconds; note angle achieved
• Progress with over-pressure

• At end-range SLR position → child contracts hamstring isometrically against therapist resistance for 6-10 seconds
• Relax → therapist moves limb further into range
• 3-4 repetitions per side; typically gains 5-10° per session

---

• Child supine; hips and knees flexed, feet together (butterfly position)
• Gentle downward pressure on inner thighs
• Hold 2-3 minutes (prolonged low-load)

• Child stands with wide stance
• Therapist supports pelvis; child shifts weight side to side
• Maintains adductor length through weight-bearing

• Child sits straddling a bench/roll; gravity provides gentle adductor stretch
• Combined with trunk activity (reaching forward, building blocks)

---

• Child lies at edge of plinth; one hip/knee held in flexion by child to stabilize pelvis
• Opposite leg hangs down over edge - gravity stretches hip flexor
• Hold 30-60 seconds; 3 repetitions each

• Child lies prone for 20-30 min (supervised)
• Hip extended position → sustained hip flexor stretch
• Combine with play activity in prone

---

MODULE 2: STRENGTHENING PROGRAM

• Position: Supine, knees bent, feet flat
• Action: Lift buttocks off plinth until hips fully extended
• Hold 3-5 seconds; lower slowly
• Sets x reps: 3 x 10; progress to: single-leg bridge, bridge with feet on unstable surface, bridge with knee extension

• Position: Standing at bottom of step (start 10cm; progress to 20cm)
• Action: Lead with affected leg; step up and bring trailing leg alongside; step down
• Sets x reps: 3 x 10 each leg
• Progress: Higher step, add resistance band, hold weight

• Position: Standard chair height
• Action: Hands on thighs → push to stand; slow controlled sit-back down
• Sets x reps: 3 x 10; progress chair height lower, add resistance band above knees

---

• Position: Side-lying; lower leg slightly bent; upper leg straight
• Action: Lift upper leg to 30-40° abduction; hold 3 seconds; lower slowly
• Sets x reps: 3 x 10; progress: resistance ankle cuff (0.5 kg start)

• Position: Standing; resistance band just above knees
• Action: Step sideways 10 steps left, 10 steps right; maintain upright trunk
• Progress: heavier band, wider steps, mini-squat position during walk

• With support → unsupported → eyes closed
• Challenges hip abductor continuously throughout single stance

---

• Position: Back against wall, hips and knees at 90°
• Hold 10-30 seconds; 3 repetitions
• Progress: Longer hold time; lower back position (more knee flexion)

• Position: Standing; resistance band behind knee
• Action: Extend knee from 30° against resistance; hold 3 seconds
• Specifically activates vastus medialis oblique (VMO)
• Sets x reps: 3 x 12

• Step down slowly (3-4 seconds) → eccentric quadriceps control
• Controls crouch gait and knee hyperextension

---

• Walk on heels for 10m (active dorsiflexion required)
• Sets: 3 passes; progress with distance

• Position: Sitting; resistance band around foot
• Action: Pull foot up (dorsiflex) against resistance; hold 3 seconds; lower slowly
• Sets x reps: 3 x 12; progress band resistance

• Eccentric TA control as foot contacts step surface

---

• Child sits on therapy ball; therapist facilitates trunk activation through perturbations
• Progress: Arm movements while sitting; reach to floor and return; feet off floor

• Position: Hands and knees; maintain neutral spine
• Action: Lift one arm; then one leg; then alternate arm/leg (bird-dog)
• Sets x reps: 3 x 10 each

• Bridge position → rotate pelvis side to side while maintaining lift
• Activates obliques and multifidus

---

MODULE 3: GAIT TRAINING PROGRAM

• High-step marching (exaggerated knee flexion in swing)
• Addresses: stiff-knee gait; hip flexion initiation
• Sets: 3 x 10 high steps each leg

• Sidestepping along parallel bars
• Activates hip abductors; corrects scissoring
• 3 x 10 steps each direction

• Step over cones of increasing height placed along path
• Trains adequate foot clearance and swing-phase knee flexion

---

• Visual feedback: mirror in front; child watches foot contact
• Cue: "heel first, then toe" at initial contact
• Auditory cue: metronome to encourage cadence
• Therapist may manually cue heel contact from behind

---

• Walk 50m circuit (corridor); rest 30 sec; repeat x 5
• Progress: increase distance; add turns; dual-task (carry object)

• Walk to cone, turn 90° right; walk to next cone, turn 90° left; etc.
• Trains rotational trunk control and hip abductor activation in turns

• Walk on carpet, grass (outdoor), ramp (5° incline), then 10°
• Prepare for real-world community mobility

• Step up and down 4-step practice stairs
• Reciprocal pattern (one foot per step) vs marking time (both feet per step)
• With handrail → without handrail
• 3 x 5 ascents/descents

---

MODULE 4: BALANCE TRAINING

• Two-hand support on parallel bars → one hand → fingertip
• Weight shift side-to-side; forward-back

• Standing with feet together, eyes open → eyes closed
• Single-leg standing 10-30 seconds
• Timed: 3 x 30 seconds each

• Standing on balance disc or foam mat
• Catch and throw ball while standing on foam
• Stepping responses to unexpected perturbations

• Walk on balance beam (10cm wide)
• Carry tray with objects while walking
• Walk and turn head (dual task cognitive + motor)

---

MODULE 5: AFO AND ORTHOTIC TRAINING

• Teach child to achieve heel-toe pattern within AFO
• Check heel contact is occurring (talc footprint test)
• Review fit every 3-6 months; replace annually or with growth

---

MODULE 6: POST-BoNT-A INTENSIVE PROTOCOL (Weeks 2-8 Post-Injection)

---

HOME PROGRAM (Given to Caregiver)

---

TREATMENT PLAN 2: SPASTIC HEMIPLEGIA (GMFCS I-II)

Case Scenario

Child: 9 years, female. Right spastic hemiplegia GMFCS Level I. Walks independently; circumduction right leg. Right arm posturing (elbow flexed, forearm pronated, wrist flexed, thumb-in-palm). MRI: left hemisphere periventricular infarct. Epilepsy controlled on levetiracetam. Struggles with writing, dressing right side.

---

PROBLEM LIST

---

GOALS

1. Improve right wrist extension ROM to ≥40° (currently 20°)
2. Improve right supination to ≥60° (currently 30°)
3. Spontaneously use right hand in at least 3 new bimanual tasks (AHA improvement ≥4 raw units)
4. Complete CIMT program (3 weeks); tolerate mitt for 4 hours/day

1. Independent dressing (buttons, zips) using right hand as active assist
2. Write legibly for 10 minutes without fatigue
3. Run without significant circumduction; participate in school sport

---

TREATMENT PROGRAM

UPPER LIMB REHABILITATION

---

• Child sits at table; arm straight on table
• Therapist or parent applies gentle over-pressure into extension
• Hold 30 seconds; 5 repetitions
• Progress: elbow extension splint at night (bivalve cast)

• Elbow at 90°; stabilise humerus
• Slowly supinate forearm to end range; hold 30 seconds
• Hold-relax PNF: isometric pronation → relax → further supination
• 5 repetitions; goal = symmetric supination

• Wrist in neutral grip; therapist supports fingers extended
• Apply gentle wrist extension over-pressure
• Hold 30 seconds; 5 repetitions
• Wrist cock-up splint at rest/night to maintain

• Thumb-in-palm: gently extend and abduct CMC joint
• Hold 30 seconds; 3 repetitions
• Neoprene thumb abduction splint worn during activities

---

---

• Cutting food (fork in R hand for stabilising; later try knife)
• Doing up buttons (right hand threads; left positions button)
• Carrying tray with two hands
• Catching ball with two hands
• Building with LEGO using both hands
• Play-based activities: board games, art, cooking

---

LOWER LIMB REHABILITATION (Hemiplegia)

• Thomas position; 30-60 seconds x 3

• Standing lunge stretch; emphasis on heel contact during running

• Single-leg stand on RIGHT leg (challenging side): 3 x 30 seconds
• Right single-leg mini-squat: 3 x 10 (works right glut max, quads)
• Step-up leading with RIGHT leg: 3 x 10

• Treadmill at increased speed to expose equinus in swing
• Video-feedback of running gait; cue heel-touch during high-speed
• Running-specific drills: high knees, butt kicks, skipping
• Right AFO (if prescribed): hinged AFO for equinus control

---

TREATMENT PLAN 3: SPASTIC QUADRIPLEGIA (GMFCS IV-V)

Case Scenario

Child: 11 years, female. Spastic quadriplegia GMFCS Level V. Fully dependent for all transfers and mobility. Powered wheelchair user. G-tube fed. Epilepsy. Right hip migration index 38% on last X-ray (6 months ago). Recent BoNT-A to bilateral hip adductors. Right scoliosis 28° Cobb. Regular chest infections.

---

PROBLEM LIST

---

GOALS

1. Improve bilateral hip abduction ROM to 20° (currently 10°) following BoNT-A to adductors
2. Serial casting to reduce right equinus to plantarflexion ≤15° (from 30°)
3. Achieve 45 minutes standing frame program daily (currently 0 min)
4. Establish daily passive ROM home program taught to caregiver (demonstrate competency)
5. Reduce chest infection frequency with established airway clearance protocol

1. Hip migration index maintained <33% (avoid surgical dislocation)
2. No new pressure injuries
3. Comfortable seating position maintained for ≥6 hours/day in wheelchair
4. Family confident in complete home management program

---

TREATMENT PROGRAM

MODULE 1: POSTURAL MANAGEMENT (24-HOUR)

• Custom sleep system with:
  • Hip abductor wedge between thighs (maintains abduction; prevents windswept deformity)
  • Knee flexion positioning wedge
  • Foot positioning block (maintains ankle near neutral; combats equinus)
  • Trunk wedges for spinal alignment
• Review: monthly initially; adjust with growth
• Purpose: 8-10 hours/night positional input → major long-term benefit on hip migration and spinal alignment

• Prone over therapy roll or wedge: 20-30 minutes, 2x daily
• Hip and knee extension; opposes dominant flexion pattern
• Caregiver supervised; check airway clearance
• Combine with back-of-hand weight-bearing for upper limb proprioception

• Custom-moulded seating insert:
  • Pelvic positioning belt at 45° (anterior pelvic stabilisation)
  • Lateral trunk supports (scoliosis management)
  • Hip abductor pommel (prevents adduction and dislocation)
  • Footplates at 90° ankle angle with foot straps
  • Headrest contoured to cervical curve
  • Tray for upper limb support and activity surface
• Seating review: every 6 months or with growth/change in tone
• Pressure mapping: to identify high-pressure areas; modify cushion accordingly

• Monitor: heart rate, skin colour, tone response
• Child can engage in communication device, reading, TV during standing

---

MODULE 2: PASSIVE ROM AND STRETCHING

---

MODULE 3: SERIAL CASTING (Right Equinus)

• Check toes: colour (pink), warmth, movement 2x daily
• Check for smell (infection sign)
• If skin breakdown/pain: attend PT/ED same day - do NOT wait
• Cast waterproof but avoid full immersion

---

MODULE 4: RESPIRATORY PHYSIOTHERAPY

• Postural drainage position based on X-ray findings:
  • Right lower lobe: Left side-lying, foot of bed elevated 15°
  • Upper lobes: High sitting or slight forward lean
• Maintain each position 5 minutes

• Cupped hand percussion over affected lobe: 1-2 min each zone
• Vibration on expiration phase
• Cover with light sheet; appropriate force for child's size

• Mask over face (or via tracheostomy if present)
• Settings: +40 cmH₂O insufflation; -40 cmH₂O exsufflation
• 5 cycles; pause; 5 cycles; pause x 2-3 sets
• Clears secretions without effort from child

• Change position after clearance to allow drainage of loosened secretions
• Oral suction if needed

---

MODULE 5: TRANSFER TRAINING AND HANDLING

• Hoist (preferred): sling selection; check weight limits; smooth transfer
• Manual (2-person if >20kg): one at head/trunk; one at hips/legs
• Use transfer belt

• Slide sheet technique for repositioning in bed
• Pivot transfer with adequate support (2 carers for GMFCS V)

• 2-hourly repositioning in bed
• Daily skin inspection: bony prominences (sacrum, heels, ischial tuberosities, ankles, elbows)
• Specialist pressure-relieving mattress; foam or air-alternating
• Foam heel protectors when supine

---

TREATMENT PLAN 4: ATAXIC CEREBRAL PALSY (GMFCS I-II)

Problem List

---

PT Treatment Focus

• Progressively destabilising surfaces: firm → foam → balance board → trampoline
• Perturbation training: unexpected pushes; tilting platform
• Eyes closed balance: removes visual compensation; forces somatosensory/vestibular use
• Gait with head turns (vestibulo-ocular reflex challenge)

• Rhythmic stabilisation through trunk
• Ball activities: tracking, catching, throwing (progressive difficulty)
• Finger-to-nose practice; heel-to-shin task for assessment AND training
• Swimming: highly recommended; buoyancy reduces ataxia impact; promotes coordination

• Trunk and proximal strengthening (hip abductors, core stabilisers)
• Improves postural base; reduces effect of ataxia on gait

• Narrow base gait progression (wide base → normal base)
• Tandem walking: heel-to-toe along line
• Treadmill with handrails: rhythmic, constrained gait; reduces ataxia
• Rollator walker (if needed) → quad stick → single stick progression

• SMO or AFO for ankle instability; reduces falls
• Weighted vest: proprioceptive input; may reduce ataxia amplitude
• Weighting of distal limbs (weighted cuffs at wrists): reduces tremor amplitude during tasks

---

SECTION 3: DOCUMENTATION AND PROGRESS NOTES

Standard SOAP Note Format (Per Session)

---

• Right ankle DF (knee ext): improved from -2° to +3° (MTS R2)
• 10MWT: 0.68 m/s (up from 0.60 m/s at baseline)
• Treadmill: 0.8 km/h x 20 min; 2 rests required
• Gait observation: reduced equinus at IC; some heel contact achieving R

• ROM improving post-serial casting (cast 2 applied today)
• Gait speed improving but heel contact still inconsistent
• Home program compliance good; caregiver competent
• On track to meet 8-week ROM goal

• Continue serial casting; cast 3 in 7 days
• Progress treadmill to 1.0 km/h next session
• Add step-up strengthening to home program
• Review AFO prescription after casting completion in 2 weeks

---

SECTION 4: STANDARD SESSION PROTOCOL SUMMARY

Standard 60-Minute Session Template (School Age, GMFCS II)

---

SECTION 5: OUTCOME MEASURE SCHEDULE

---

SECTION 6: ESCALATION AND MDT COMMUNICATION

Red Flags Requiring Immediate Referral

MDT Communication Points

• Before BoNT-A clinic: Provide physiatrist with current MTS, ROM, gait video, GMFM scores, and specific muscles PT recommends for injection
• After BoNT-A: Confirm injection sites received; plan intensive casting/therapy window
• Before orthopaedic review: Provide hip X-ray migration trends, gait analysis summary, ROM progression data
• School liaison: Regular reports to school PT/teacher; mobility aids for school; PE adaptations

---

• Bradley and Daroff's Neurology in Clinical Practice - Chapter 111
• Campbell's Operative Orthopaedics 15th Ed 2026
• Novak I et al. State of Evidence Traffic Lights 2019 - Curr Neurol Neurosci Rep 2020 (PMID 32086598)
• Das & Ganesh, Evidence-Based Physical Therapy in CP - Indian J Orthop 2019
• Alotaibi et al. PBWSTT Meta-Analysis - Children 2024
• RCH Melbourne CP Clinical Practice Guidelines
• NHS CP Physiotherapy Guidelines
• AACPDM Care Pathways